Agoulnik Irina U, Hodgson Myles C, Bowden Wayne A, Ittmann Michael M
Herbert Wertheim College of Medicine, Miami, FL, USA. email:
Oncotarget. 2011 Apr;2(4):321-8. doi: 10.18632/oncotarget.260.
Dysregulation of phosphatidyl inositol signaling occurs in many cancers and other disorders. The lipid and protein phosphatase, PTEN (Phosphatase and Tensin homology protein on chromosome 10), is a known tumor suppressor whose function is frequently lost in various malignancies due to mutations in the coding region or genomic deletions. Recently, another lipid phosphatase, Inositol Polyphosphate 4-phosphatase type II (INPP4B), has emerged as a potential tumor suppressor in prostate, breast, and ovarian cancers and possibly in leukemia. We will review its structure and function, crosstalk with androgen receptor signaling, and regulation of INPP4B expression, as well as existing data about its role in cancer.
磷脂酰肌醇信号失调在许多癌症和其他疾病中都会出现。脂质和蛋白质磷酸酶PTEN(第10号染色体上的磷酸酶和张力蛋白同源蛋白)是一种已知的肿瘤抑制因子,由于编码区突变或基因组缺失,其功能在各种恶性肿瘤中经常丧失。最近,另一种脂质磷酸酶,即II型肌醇多磷酸4-磷酸酶(INPP4B),已成为前列腺癌、乳腺癌和卵巢癌以及可能在白血病中的一种潜在肿瘤抑制因子。我们将综述其结构和功能、与雄激素受体信号的相互作用、INPP4B表达的调控,以及关于其在癌症中作用的现有数据。